Angiogenesis and antiangiogenic therapy in hematologic malignancies
- PMID: 17188504
- DOI: 10.1016/j.critrevonc.2006.11.006
Angiogenesis and antiangiogenic therapy in hematologic malignancies
Abstract
Angiogenesis, the generation of new blood capillaries from preexisting blood vessels, is tightly regulated in the adult organism. Although many of the initial studies were performed on solid tumors, increasing evidence indicates that angiogenesis also plays an important role in hematologic malignancies. Overexpression of angiogenic factors in particular VEGF and bFGF in most hematologic malignancies may explain the increased angiogenesis found in these malignancies and correlate with poor prognosis as well as decreased overall survival. In this review, we focus on the current literature of angiogenesis and antiangiogenic therapy in hematologic malignancies, and finally describe advances and potential challenges in antiangiogenic treatment in hematologic malignancies.
Similar articles
-
[Angiogenesis and hematologic malignancy].Bull Cancer. 2007 Jul;94 Spec No:S241-6. Bull Cancer. 2007. PMID: 17846010 Review. French.
-
Angiogenesis in hematologic malignancies.Ann Hematol. 2001 Dec;80(12):695-705. doi: 10.1007/s00277-001-0398-3. Epub 2001 Nov 14. Ann Hematol. 2001. PMID: 11797109 Review.
-
[Angiogenesis and hematological malignancies].Tidsskr Nor Laegeforen. 2003 Nov 20;123(22):3198-200. Tidsskr Nor Laegeforen. 2003. PMID: 14714007 Review. Norwegian.
-
Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.Expert Rev Anticancer Ther. 2004 Feb;4(1):129-40. doi: 10.1586/14737140.4.1.129. Expert Rev Anticancer Ther. 2004. PMID: 14748663 Review.
-
[Angiogenesis and antiangiogenic cancer therapy].Vnitr Lek. 2004 Dec;50(12):930-8. Vnitr Lek. 2004. PMID: 15717808 Review. Czech.
Cited by
-
Dual Effects of Resveratrol on the Expression and Secretion of Angiogenic Factors.Int J Mol Cell Med. 2022;11(1):16-30. doi: 10.22088/IJMCM.BUMS.11.1.16. Epub 2022 Oct 3. Int J Mol Cell Med. 2022. PMID: 36397806 Free PMC article.
-
Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.PPAR Res. 2010;2010:814609. doi: 10.1155/2010/814609. Epub 2010 Feb 28. PPAR Res. 2010. PMID: 20204067 Free PMC article.
-
Plant proteolytic enzyme papain abrogates angiogenic activation of human umbilical vein endothelial cells (HUVEC) in vitro.BMC Complement Altern Med. 2013 Sep 21;13:231. doi: 10.1186/1472-6882-13-231. BMC Complement Altern Med. 2013. PMID: 24053149 Free PMC article.
-
Hypoxia-Inducible Factor1-Α (HIF1α) and Vascular Endothelial Growth Factor-A (VEGF-A) Expression in De Novo AML Patients.Asian Pac J Cancer Prev. 2019 Mar 26;20(3):705-710. doi: 10.31557/APJCP.2019.20.3.705. Asian Pac J Cancer Prev. 2019. PMID: 30909668 Free PMC article.
-
Prognostic impact of angiopoietin-2 in multiple myeloma.J Cancer Res Clin Oncol. 2014 Oct;140(10):1801-5. doi: 10.1007/s00432-014-1731-2. Epub 2014 Jun 8. J Cancer Res Clin Oncol. 2014. PMID: 24906877
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources